REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi Saglik Urunleri Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi Saglik Urunleri Limited Sirketi Profile Updated: January 19, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Sanofi Saglik Urunleri Ltd. Sti. is a health company with a presence in over 100 countries. They offer healthcare solutions, including general medicines, vaccine products, and consumer health care products. Sanofi Saglik Urunleri Ltd. Sti. is focused on improving human life through therapies and treatments, with a presence in the health industry. They operate in the fields of immunology, oncology, neurology, and multiple sclerosis, with a focus on research and development. The company has a Rare Humanitarian program that supports people managing various rare diseases.

Headquarters
193 Apartmani No:193-15 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.

Website: http://www.sanofi.com.tr

Basic Information
Total Employees:
Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.
Incorporation Date:
January 23, 2001
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Sanofi Saglik Urunleri Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
148.81%
Total operating revenue
148.81%
Operating Profit/Loss (EBIT)
-28.36%
Net Profit/Loss for the Period
-28.36%
Total Assets
309.87%
Total Equity
-57.34%
Operating Profit Margin (ROS)
-12.82%
Net Profit Margin
-12.82%
Return on Equity (ROE)
43.28%
Quick Ratio
-1.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?